Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Tarsus Pharmaceuticals, Inc. TARS

Set alert

Price alert · TARS

All alert types
73.32 USD -1.53 -2.04%

At close · Nov 2

73.32 0.00 0.00%

After hours · Nov 2, 4:00 PM ET

Bid
73.32 × 2
Ask
73.39 × 2
72.43 Day range 75.95
53.89 52-week range 91.53
YTD
-10.45%
1 year
+6.55%
Open
74.88
Prev close
74.85
Mkt cap
3.43B
Vol
428.69K
Avg vol
828.48K
EPS
-1.08
P/E
0.00
Div yield
0.00%
More statistics
Low
72.43
High
75.95
Forward P/E
-146.64
Beta
0.33
Short ratio
6.62
Inst. own
99.26%
Dividend
0.00
Ex-div date
Earnings
Nov 3, 2026
50-d avg
75.16
200-d avg
67.78
1y target
98.89

5D chart

Chart tools
Interval
1m5m15m30m

Signals (126)
NameTimeAgo
SMA: BullishNov 2, 12:15 PM19 hours ago
SMA: BullishNov 2, 11:35 AM19 hours ago
MACD: Buy SignalNov 2, 11:35 AM19 hours ago
RSI: OversoldNov 2, 10:50 AM20 hours ago
SMA: BearishNov 2, 9:55 AM21 hours ago
MACD: Sell SignalNov 2, 9:55 AM21 hours ago
SMA: BullishNov 2, 9:50 AM21 hours ago
SMA: BearishNov 2, 9:40 AM21 hours ago
SMA: BearishNov 2, 9:40 AM21 hours ago
SMA: BullishNov 2, 9:30 AM21 hours ago
SMA: BearishOct 30, 3:55 PM3 days ago
SMA: BullishOct 30, 3:45 PM3 days ago
SMA: BullishOct 30, 3:45 PM3 days ago
MACD: Buy SignalOct 30, 3:45 PM3 days ago
SMA: BearishOct 30, 3:35 PM3 days ago
SMA: BullishOct 30, 3:30 PM3 days ago
MACD: Sell SignalOct 30, 2:30 PM3 days ago
SMA: BearishOct 30, 2:20 PM3 days ago
SMA: BullishOct 30, 2:15 PM3 days ago
SMA: BearishOct 30, 2:05 PM3 days ago

Newest 20 of 126.

Analyst view

Consensus: strong buy

Strong buy
Price target (mean) 98.89 +34.9% upside
Target (low)
84.00
Target (mean)
98.89
Target (high)
116.00
Ratings (0m) 10 10 buy · 0 hold · 0 sell
  • Strong buy1
  • Buy9
  • Hold0
  • Sell0
  • Strong sell0

Recommendation trend

  • This month 10
  • 1 month ago 10
  • 2 months ago 7

Earnings and revenue estimates

Consensus for the coming quarters and fiscal years

TARS analyst estimates
PeriodEPS estimateLow – highYear agoEPS growthRevenue estimateRevenue growthAnalysts
Current quarter-1.77-2.01 – -1.46-0.30-490.0%190.78M+60.7%3
Next quarter-4.82-9.57 – -0.07-0.20-2310.0%210.89M+39.0%2
Current year-5.79-11.63 – -2.52-1.59-264.4%736.88M+63.3%3
Next year-0.50-1.59 – 1.04-5.79+91.4%920.04M+24.9%3

Upgrades and downgrades

The latest rating changes

TARS analyst upgrades and downgrades
DateFirmActionFromTo
Sep 8, 2026JefferiesMaintainedBuyBuy
Aug 12, 2026OppenheimerMaintainedOutperformOutperform
Jul 31, 2026MizuhoMaintainedOutperformOutperform
Jul 21, 2026GuggenheimMaintainedBuyBuy
Jul 9, 2026HC Wainwright & Co.ReiteratedBuyBuy
May 4, 2026HC Wainwright & Co.ReiteratedBuyBuy
Feb 25, 2026OppenheimerMaintainedOutperformOutperform
Feb 25, 2026GuggenheimMaintainedBuyBuy
Dec 9, 2025BarclaysInitiated—Overweight
Nov 20, 2025MizuhoInitiated—Outperform
Nov 5, 2025GuggenheimMaintainedBuyBuy
Oct 20, 2025HC Wainwright & Co.MaintainedBuyBuy
May 5, 2025Goldman SachsMaintainedNeutralNeutral
May 2, 2025GuggenheimMaintainedBuyBuy
Mar 6, 2025JefferiesMaintainedBuyBuy
Feb 26, 2025GuggenheimMaintainedBuyBuy
Feb 26, 2025HC Wainwright & Co.ReiteratedBuyBuy
Feb 26, 2025BarclaysMaintainedOverweightOverweight
Feb 24, 2025GuggenheimReiteratedBuyBuy
Feb 10, 2025GuggenheimReiteratedBuyBuy
Jan 27, 2025BarclaysMaintainedOverweightOverweight
Jan 22, 2025OppenheimerMaintainedOutperformOutperform
Nov 15, 2024Goldman SachsMaintainedNeutralNeutral
Nov 14, 2024OppenheimerMaintainedOutperformOutperform
Aug 9, 2024OppenheimerReiteratedOutperformOutperform
May 13, 2024HC Wainwright & Co.MaintainedBuyBuy
May 10, 2024BarclaysMaintainedOverweightOverweight
May 9, 2024OppenheimerMaintainedOutperformOutperform
Mar 6, 2024JefferiesMaintainedBuyBuy
Feb 29, 2024Goldman SachsMaintainedNeutralNeutral